Q/C Technologies (QCLS) News
NASDAQ: QCLSHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
QCLS news summary
We found 2 recent headlines mentioning Q/C Technologies (QCLS): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. QCLS is making an outsized move today, down 6.01% at $0.2784, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "TNF Pharmaceuticals, Inc. Enters into Omnibus Amendment Agreement and Modifies Rights of Security Holders", was published by Nasdaq on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Q/C Technologies headlines
- TNF Pharmaceuticals, Inc. Enters into Omnibus Amendment Agreement and Modifies Rights of Security HoldersOn November 20, 2026, Q/C Technologies, Inc. entered into an Omnibus Amendment Agreement with PharmaCyte Biotech, Inc., which holds at least a majority of the outstanding shares of each of the…Nasdaq
- Q/C Technologies Reports Over $10 Million in Cash and Investments to Fund Development of Its Optical Processing UnitCompany is developing an optical processing unit (OPU) designed to accelerate core AI computations using light, targeting energy constraints facing AI infrastructureGlobeNewswire